M, R., A, A., & W, W. (2022). PROCAM based myocardial infarction risk in relation to global vascular disease risk: Observations from the ARCO cohort study. Swiss medical weekly, 152, w30111. https://doi.org/10.4414/smw.2022.w30111
Chicago Style (17th ed.) CitationM, Romanens, Adams A, and Warmuth W. "PROCAM Based Myocardial Infarction Risk in Relation to Global Vascular Disease Risk: Observations from the ARCO Cohort Study." Swiss Medical Weekly 152 (2022): w30111. https://doi.org/10.4414/smw.2022.w30111.
MLA (9th ed.) CitationM, Romanens, et al. "PROCAM Based Myocardial Infarction Risk in Relation to Global Vascular Disease Risk: Observations from the ARCO Cohort Study." Swiss Medical Weekly, vol. 152, 2022, p. w30111, https://doi.org/10.4414/smw.2022.w30111.